These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 22583443
1. In vitro and in vivo models of multiple sclerosis. van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S. CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443 [Abstract] [Full Text] [Related]
2. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Rodriguez M. Brain Pathol; 2007 Apr; 17(2):219-29. PubMed ID: 17388953 [Abstract] [Full Text] [Related]
3. Deleterious versus protective autoimmunity in multiple sclerosis. Kostic M, Stojanovic I, Marjanovic G, Zivkovic N, Cvetanovic A. Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389 [Abstract] [Full Text] [Related]
7. Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis. Hamilton AM, Forkert ND, Yang R, Wu Y, Rogers JA, Yong VW, Dunn JF. Sci Rep; 2019 Jun 11; 9(1):8488. PubMed ID: 31186441 [Abstract] [Full Text] [Related]
12. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH. Exp Neurol; 2009 Nov 07; 220(1):44-56. PubMed ID: 19616545 [Abstract] [Full Text] [Related]
13. Pathogenesis of multiple sclerosis: an update on immunology. Hemmer B, Cepok S, Nessler S, Sommer N. Curr Opin Neurol; 2002 Jun 07; 15(3):227-31. PubMed ID: 12045717 [Abstract] [Full Text] [Related]
14. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Stinissen P, Raus J, Zhang J. Crit Rev Immunol; 1997 Jun 07; 17(1):33-75. PubMed ID: 9034723 [Abstract] [Full Text] [Related]
15. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. Nastasijevic B, Wright BR, Smestad J, Warrington AE, Rodriguez M, Maher LJ. PLoS One; 2012 Jun 07; 7(6):e39595. PubMed ID: 22761835 [Abstract] [Full Text] [Related]
16. Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond. Kipp M, van der Star B, Vogel DY, Puentes F, van der Valk P, Baker D, Amor S. Mult Scler Relat Disord; 2012 Jan 07; 1(1):15-28. PubMed ID: 25876447 [Abstract] [Full Text] [Related]
17. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective. Skundric DS. Curr Neurovasc Res; 2005 Oct 07; 2(4):349-62. PubMed ID: 16181126 [Abstract] [Full Text] [Related]
18. Mouse models of multiple sclerosis: lost in translation? Baker D, Amor S. Curr Pharm Des; 2015 Oct 07; 21(18):2440-52. PubMed ID: 25777759 [Abstract] [Full Text] [Related]
19. Experimental models of demyelination and remyelination. Torre-Fuentes L, Moreno-Jiménez L, Pytel V, Matías-Guiu JA, Gómez-Pinedo U, Matías-Guiu J. Neurologia (Engl Ed); 2020 Oct 07; 35(1):32-39. PubMed ID: 28863829 [Abstract] [Full Text] [Related]
20. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Dal Canto MC, Melvold RW, Kim BS, Miller SD. Microsc Res Tech; 1995 Oct 15; 32(3):215-29. PubMed ID: 8527856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]